WebCisplatin, a platinum analogue, is an alkylating agent used in combination with other agents to treat a variety of solid malignancies, including lung cancer, head and neck cancer, … WebPurpose: The objective of this study was to develop a pH-dependent calcium carbonate nano-delivery system for the combination therapy of CDDP with oleanolic acid (OA). Methods: A microemulsion method was employed to generate lipid coated cisplatin/oleanolic acid calcium carbonate nanoparticles (CDDP/OA-LCC NPs), and the …
The UV visible spectrum of cisplatin solution. Download …
WebThe anticancer drug cisplatin hydrolyzes in water with a rate constant of 1.5 × 10 −3 min −1 at pH 7.0 and 25°C. Calculate the half-life for the hydrolysis reaction under these conditions. If a freshly prepared solution of cisplatin has a concentration of 0.053 M, what will be the concentration of cisplatin after 5 half-lives? after 10 half-lives? WebApr 10, 2024 · Triple-negative breast cancer (TNBC) is one of the most aggressive forms of breast cancer and constitutes 10–20% of all breast cancer cases. Even though platinum-based drugs such as cisplatin and carboplatin are effective in TNBC patients, their toxicity and development of cancer drug resistance often hamper their clinical use. Hence, novel … early sow grass seed
Cisplatin - NCI - National Cancer Institute
WebNano-zinc carrier equivalent to 10 μM of USP14 siRNA was mixed in 100 μL of deionized water at pH 5.2, pH 6.2, or pH 7.4. The nano-zinc carrier mixes were incubated at 37°C … WebDosisnya 75–100 mg/m2 luas permukaan tubuh (LPT) per siklus, tiap 4 minggu. Obat ini akan dikombinasikan dengan cyclophosphamide. Kondisi: Kanker testis yang sudah menyebar. Dosisnya 20 mg/m2 LPT selama 5 hari per siklus. Dosis akan diulangi kembali tiap 3 minggu. Obat akan dikombinasikan dengan bleomycin dan etoposide. WebCisplatin (PIM 132) Cisplatin 1. NAME 1.1 Substance 1.2 Group 1.3 Synonyms 1.4 Identification Numbers 1.4.1 CAS 1.4.2 Other Numbers 1.5 Brand Names, Trade Names 1.6 Manufacturers, Importers 1.7 Presentation, Formulation 2. SUMMARY 2.1 Main Risks and Target Organs 2.2 Summary of Clinical Effects 2.3 Diagnosis csuf ms applied math